Premier Inc.
04/02/2026 | Press release | Archived content
Federal Court Strikes Down HRSA’s 340B Hospital Drug Purchasing Restrictions Policy
*:last-child]:mb-0 [&>*:last-child]:pb-0 [&>p]:font-normal text-left [&>.prm-button-bar]:justify-start [&_.portable-text-link]:font-semibold [&_.portable-text-link]:underline [&_.prm-button-bar_a]:no-underline [&_li]:text-light-gray [&_p]:text-light-gray">
340B Report covers a federal court decision striking down a 2013 Health Resources and Services Administration (HRSA) policy that restricted how certain hospitals participating in the 340B program purchase initial drug inventory. A Washington, D.C., federal district judge ruled in favor of Premier Inc., which challenged the policy prohibiting hospitals from using either 340B discounts or group purchasing organization-negotiated discounts for initial drug purchases.
Read the full story on 340B Report.
Premier Inc. published this content on April 02, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 08, 2026 at 15:45 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]